School of Medicine
Showing 1-100 of 100 Results
-
Alison Barrett
Postdoctoral Scholar, Immunity Transplant Infection
BioI'm an all-in-one biochemist, cell-culturist, and human-health enthusiast whose interests include therapeutics development, and tools for medical diagnostics.
I strive to maintain a healthy balance of breadth and depth in my areas of expertise, and have a strong affinity to interdisciplinary approaches. My background includes software development within the protein structure prediction module of the Rosetta software suite, design and initial development of cancer therapeutics, and basic research into understanding the mechanistic details of cell-cycle gene regulation.
My current research within the Tobias Lanz Lab aims to understand the role of certain targets of autoimmunity in Multiple Sclerosis and use this understanding to develop therapies and diagnostic aides. -
Cort Breuer
Ph.D. Student in Immunology, admitted Autumn 2022
BioCort Breuer is currently an Immunology PhD student in the lab of Nathan Reticker-Flynn. Cort received his BS in Biological Engineering from Cornell University in 2022, where he studied lymphatic-cancer interactions and T cell mechanosensing in the lab of Esak Lee. Previously, he worked with James Moon at Massachusetts General Hospital to develop in vivo gene therapies for the immune system and with Michelle Krogsgaard at NYU Perlmutter Cancer Center to investigate structural biology of TCR signaling. Cort’s current work focuses on mechanisms of tumor-immune tolerance and decoding the antigen specificity of T cell receptors. Drawing on his engineering background, he designs new molecular tools to record how immune cells communicate and constructs therapeutics to target impaired immune responses.
-
Tejas Dharmaraj
MD Student, expected graduation Spring 2026
Ph.D. Student in Immunology, admitted Autumn 2020
MSTP StudentBioTejas Dharmaraj is an MD/PhD candidate at Stanford University. He completed his PhD in Immunology, where he developed tools to engineer bacteriophage therapies for multidrug-resistant Pseudomonas wound infections. Tejas earned his bachelor’s degree in Molecular and Cellular Biology from Johns Hopkins University. His research background spans antimicrobial resistance, drug delivery systems, and host-pathogen interactions.
-
Caroline Duncombe
Postdoctoral Scholar, Immunity Transplant Infection
BioDr. Caroline Duncombe is a Postdoctoral Scholar in the Institute for Immunity, Transplantation, and Infection at Stanford University. Her research broadly explores how sex-based differences influence immune responses to infectious diseases. She applies systems-level approaches to investigate molecular and cellular mechanisms underlying immune variation, with the goal of informing more equitable and effective interventions.
Dr. Duncombe earned her PhD in Pathobiology from the University of Washington, where she pursued interdisciplinary research integrating systems biology, immunology, epidemiology, endocrinology, and parasitology. Her work has contributed to a deeper understanding of how sex and sex hormones shape host-pathogen interactions and vaccine responses.
In addition to her academic research, Dr. Duncombe is committed to science communication. She has produced science-focused comedy shows for over four years, using storytelling and humor to make complex scientific ideas more accessible.
Personal Website: carolinethescientist.com
LinkedIn Profile: linkedin.com/in/caroline-duncombe-phd-4ba11a124 -
David Furman
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
BioDavid Furman is the Director of the Stanford 1,000 Immunomes Project and the Buck Institute Artificial Intelligence Platform. Dr. Furman obtained his Doctoral degree in Biochemistry and Immunology (summa cum laude) from the School of Medicine, University of Buenos Aires, Argentina, for his work on cancer immune-surveillance. During his Postdoc at the laboratory of Professor Mark M Davis (Stanford), he conducted cutting-edge research in Data Science and Systems Immunology to answer scientific questions with strong potential for translational medicine, including the effect of aging, gender and common viral infections in immune system functioning. Dr. Furman’s work focuses in Data Science applied to inflammation and aging. Before joining as an Adjunct Investigator at the National Scientific and Research Council (CONICET), Buenos Aires, Argentina, Dr. Furman was Senior Scientist at the Institute for Immunity, Transplantation and Infection (ITI), Stanford, and his work involved the use of high-bandwidth/high-throughput technologies and Machine Learning tools to better define the health of the human immune system and its implications on age-related disease.
-
Anna Howley
Ph.D. Student in Immunology, admitted Autumn 2024
BioAnia Howley is an Immunology PhD student. She received her BS in Biology from College of the Holy Cross in 2022, where she investigated the function of APOBEC3G variants in the context of HIV infection. After completing her degree, she joined the Wyss Institute for Biologically Inspired Engineering at Harvard University. Using an organ-on-chip model, she studied the effects of radiation-induced injury on human bone marrow and developed an in-vitro model of Shwachman Diamond Syndrome using shRNA-based knockdown in primary CD34+ progenitor cells.
-
Anandi Krishnan
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
Visiting Scholar, Institute for Immunity, Transplantation, and Infection OperationsBioDr. Krishnan is a translational scientist with experiences in engineering, biosciences, molecular genetics and hematology. Having recently completed her NIH clinical scientist career development award (NHGRI 1K08HG010061-01A1, 2018-24), and NIH-supported research re-entry (NCATS 3UL1TR001085-04S1, 2016-18), Anandi’s interests are in expanding our understanding of the multifaceted function of anucleate blood platelets and their parent megakaryocytes in human disease.
Her current work, applying platelet transcriptome profiling and machine learning principles, aims to nominate novel clinically relevant strategies for personalized cancer and antiplatelet/antithrombotic therapy. Continued development of this research is likely to identify key mechanistic variables in platelet- and megakaryocyte-specific response to health and disease.
Recent contributions in both computational and mechanistic components of platelet and blood research lay the groundwork for sustaining contributions to the field of hematology genomic medicine (e.g. Shen et al PMID 34755136, Seetharam et al PMID 36712071, Kelliher et al PMID 37961700, Thomas & Krishnan PMID 38175681, Abbonante et al PMID 38165147, Jutzi et al PMID 35763665, Campbell et al PMID 36194487). Anandi was also was one of the first non-MD PhD scientist to be awarded the NHGRI K08 Clinical Scientist Research Career Development Award, the HTRS Mid-Career Research Award, and the MPN Research Foundation Challenge Grant Award, reflecting her consistent efforts bridging basic and clinical disciplines.
Select other recognitions include:
Member, Editorial Board, Journal of Thrombosis and Haemostasis (2024-)
Ad hoc Reviewer, NIH CSR Cancer and Hematological Disorders Study Section (2023, 24)
Host Mentor, ISTH Training Fellowship, International Society for Thrombosis and Haemostasis (2023)
Member, Minority Recruitment Initiatives Subcommittee, American Society of Hematology (2022-26)
Team Science Leadership Program at Stanford Medicine (2022)
Peer Mentor, Pathology Stanford Network for Advancement and Promotion (2021)
Research Mentor, Meharry Medical College, Nashville, Meharry-Stanford initiative *mentee selected for oral presentation & won 2nd place at Meharry (2021)
Thrombosis & Hemostasis Societies of North America Young Investigator Award (2020)
Invited Member and Panelist, NSF RESET Conference (2020)
Invited Member/Panelist, iRelaunch Return to Work Conference, Stanford Alumni Association (2018)
Featured twice by NIH NCATS in the ‘Features & Briefs’ & ‘Diversity Awardee Profiles’ webpages (2017,18)
Complete list of publications: https://pubmed.ncbi.nlm.nih.gov/?term=anandi+krishnan&sort_order=asc -
Wanlu Liu
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
Visiting Scholar, Institute for Immunity, Transplantation, and Infection OperationsBioAcademic Appointments
- Associate Professor, Zhejiang University
- Visiting Scholar, Stanford University School of Medicine (Mark M. Davis Lab)
Professional Education
- Ph. D., UCLA, Molecular Biology/Bioinformatics (2018)
- B.Med., Zhejiang University School of Medicine (2013)
Selected Publications:
- Ruonan Tian#, Zhejian Yu#, Ziwei Xue, Lize Wu, Jiaxin Wu, Shuo Cai, Bing Gao, Bing He, Yu Zhao, Jianhua Yao, Linrong Lu, Wanlu Liu*; Evaluation of T cell receptor construction methods from scRNA-seq data, Genomics Proteomics & Bioinformatics, 2025, 22(6), qzae086
- Ziwei Xue#, Lize Wu#, Ruonan Tian, Bing Gao, Yu Zhao, Bing He, Di Sun, Bingkang Zhao, Yicheng Li, Kaixiang Zhu, Lie Wang, Jianhua Yao*, Wanlu Liu*, Linrong Lu*; Integrative Mapping of Human CD8+ T Cell in Inflammation and Cancer, Nature Methods, 2025, 22(2), 435-445
- Jian Zhang#, Ruonan Tian#, Jie Yuan#, Zhang Siwen, Zhexu Chi, Weiwei Yu, Qianzhou Yu, Zhen Wang, Sheng Chen, Mobai Li, Dehang Yang, Tianyi Hu, Qiqi Deng, Xiaoyang Lu, Xue Zhang, Jia Liu, Wanlu Liu*, Di Wang*; A two-front nutrient supply environment fuels small intestinal physiology through differential regulation of nutrient absorption and host defense, Cell, 2024, 187(22), 6251-6271.
- Yaqi Su, Zhejian Yu, Siqian Jin, Zhipeng Ai, Ruihong Yuan, Xinyi Chen, Ziwei Xue, Yixin Guo, Di Chen, Hongqing Liang, Zuozhu Liu, Wanlu Liu*; Comprehensive assessment of mRNA isoform detection methods for long-read sequencing data, Nature Communications, 2024, 15, 3972
- Yixin Guo, Ziwei Xue, Meiting Gong, Siqian Jin, Xindi Wu, Wanlu Liu*; CRISPR-TE: a web-based tool to generate single guide RNAs targeting transposable elements, Mobile DNA, 2024, 14(1), 3
- Xinyu Xiang#, Yu Tao#, Jonathan DiRusso, Fei-Man Hsu, Jinchun Zhang, Ziwei Xue, Julien Pontis, Didier Trono, Wanlu Liu*, Amander T. Clark*; Human reproduction is regulated by retrotransposons derived from ancient Hominidae-specific viral infections, Nature Communications, 2022
- Lize Wu#, Ziwei Xue#, Siqian Jin, Jinchun Zhang, Yixin Guo, Yadan Bai, Xuexiao Jin, Chaochen Wang, Lie Wang, Zuozhu Liu, James Q. Wang, Linrong Lu*, Wanlu Liu*; huARdb: human Antigen Receptor database for interactive clonotype-transcriptome analysis at the single-cell level, Nucleic Acids Research, 2021, gkab857
- Yixin Guo, Ziwei Xue, Ruihong Yuan, Jingyi Jessica Li, William A. Pastor, Wanlu Liu*; RAD: a web application to identify region associated differentially expressed genes, Bioinformatics, 2021, 37(17): 2741-2743. -
XIAOHUA LUO
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
Visiting Scholar, Institute for Immunity, Transplantation, and Infection OperationsBioAcademic Appointments
- Visiting Scholar, Stanford University School of Medicine (Holden Maecker Lab)
- Chief Physician / Associate Professor / Associate Research Scientist, The First Affiliated Hospital of Chongqing Medical University
Professional Education
- Visiting Scholar, Karolinska Institutet (Per Ljungman & Markus Maeurer Lab) (2016)
- Ph. D., Peking University Health Science Centre (2009)
- B.Med., Tongji Medical College, Huazhong University of Science and Technology (2001)
Selected Publications:
- Luo XH*, Zhu Y, Duan XQ, Peng W, Pei CX, Yang L, Li Q, Zhao M, Wang L. Histone HIST1 genes and tumor-infiltrating lymphocytes in a child with γδ T cell acute lymphoblastic leukemia by single-cell sequencing. Journal of Leukocyte Biology. 2025 Apr;117(4):qiaf022.
- Shui LP, Zhu Y, Duan XQ, Chen YT, Yang L, Tang XQ, Zhang HB, Xiao Q, Wang L, Liu L, Luo XH*. HBsAg (‐)/HBsAb (‐)/HBeAg (‐)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B ‐ cell lymphoma receiving rituximab based immunochemotherapy. Journal of Medical Virology. 2023 Feb 3.
- Luo XH*, Poiret T, Liu Z, Meng Q, Nagchowdhury A, Ljungman P. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse. Frontiers in Immunology. 2022;13.
- Luo XH*, Zhu Y, Chen YT, Shui LP, Liu L. CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update. Frontiers in immunology. 2021;12.
- Luo XH*, Meng Q, Liu Z, Paraschoudi G. Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21. Clinical Immunology. 2020 Aug 1;217:108456.
- Li S, Huang J, Zhang YL, Zhu Y, An YF, Du J, Zhang ZL, Xia Y, Liu L, Wang L, Luo XH*. Wiskott- Aldrich syndrome protein may be critical for CD8+ T cell function following MCMV infection. Cellular immunology. 2019 Apr 1;338:43-50.
- Luo XH, Meng Q, Rao M, Liu Z, Paraschoudi G, Dodoo E, Maeurer M. The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer. Immunology. 2018 Nov;155(3):294-308.
- Zhenjiang L, Rao M, Luo X, Valentini D, von Landenberg A, Meng Q, Sinclair G, Hoffmann N, Karbach J, Altmannsberger HM, Jäger E. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme. EBioMedicine. 2018 Jul 1;33:49-56.
- Liu Zhenjiang, Martin Rao, Xiaohua Luo, Elisabeth Sandberg, Jiri Bartek Jr, Esther Schoutrop, Anna von Landenberg, Qingda Meng, Davide Valentini, Thomas Poiret, Georges Sinclair, Inti- Harvey Peredo, Ernest Dodoo, and Markus Maeurer*. Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis. EBioMedicine. 2017 Sep; 23: 20–24.
- Liu Z, Poiret T, Persson O, Meng Q, Rane L, Bartek J, Karbach J, Altmannsberger HM, Illies C, Luo X, Harvey-Peredo I. NY-ESO-1-and survivin-specific T-cell responses in the peripheral blood from patients with glioma. Cancer Immunology, Immunotherapy. 2018 Feb 1;67(2):237- 46.
- Liu Z, Meng Q, Bartek Jr J, Poiret T, Persson O, Rane L, Rangelova E, Illies C, Peredo IH, Luo X, Rao MV. Tumor-infiltrating lymphocytes (TILs) from patients with glioma. Oncoimmunology. 2017 Feb 1;6(2):e1252894.
- XH Luo, XJ Huang*, KY Liu, LP Xu, DH Liu. Protective immunity transferred by infusion of CMV- specific CD8+ T cells within donor grafts: its associations with CMV reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16(7):994-1004
- XH Luo, YJ Chang, LP Xu, DH Liu, KY Liu, XJ Huang*. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical haematopoietic SCT. Bone Marrow Transplant 2009; 43(1):29-36.
